2026-08-18 (legs over 3 days to 2026-08-20): GELFOND RICHARD L (Director, Chief Executive Officer) — scheduled sell (10b5-1 plan) — $24.0M of IMAX (open-market, Form 4, code S) [10b5-1 plan] [exercise-and-sell: sold 456,757 sh, 356,757 of them (78%) exercised the same day at $31.90 vs a $52.51 avg sale — $11.4M cost to acquire, $12.6M net; the held position FELL by 100,000 on the day — that many of the shares sold came out of stock the filer already held] [CORRECTION 2026-08-28: published as a plain scheduled sale with `xsell:0` — the detector ran on this filing and returned a negative. It is keyed to transaction code M, and this filer reports his option exercises under code C: two derivative legs titled "stock options (to buy)" at a $31.90 exercise price, underlying "common shares", and F1 says "Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan". Code C is also the letter a SHARE CLASS converts under, which is why it was excluded — so the test is now the surrendered derivative's own title and strike, and a class conversion (empty exercise price, a class name) still reads as one. 356,757 of the 456,757 shares sold (78.1%) were made that morning at a $11.4M strike bill; the direct holding closed 2026-08-18 and 2026-08-19 exactly where it opened and the only real reduction is 100,000 shares on 08-20. The dollars, the actor, the direction and the 10b5-1 claim are unchanged and were always right; what changes is the class and the position-reduction reading. The sentence above is the one the fixed reader publishes for this filing today, re-derived from the filing itself for this repair rather than edited. Original text in signal_events]
SEC Form 4 on EDGAR permalink 0001214659-26-010664